Sher East

@Calvsams Great thread. Any thoughts on what will happen on May 5th earnings?

This is my last friendly reminder that you can buy $1.40-1.50 in cash per share for 88 cents, with a business thrown in for free. $lab

Any $lab owners out there? Standard Biotools, f/k/a Fluidigm, was recapped by Viking and Casdin in April ’22 after a failed sales process. Viking/Casdin backed a private vehicle led by Dr. Michael Egholm (former CTO of Danaher LS) to build a platform for high-impact, sub-scale tools. Their first deal was injecting $250m to reset the business and pursue M&A. 1/